Analysis of HIV-type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 47, Issue 1, 2005, Pages 1-5

  Machado, Daisy Maria ^a,b   Fernandes, Silvana Cláudia ^a   Succi, Regina Célia De Menezes ^b   Freire, Wilton Santos ^a   Pannuti, Cláudio Sérgio ^a   Gouveia, Aída Barbosa ^b   Levi, José Eduardo ^a   Diaz, Ricardo Sobie ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiretroviral therapy; Children; HIV resistance; Treatment failure

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ANTIVIRAL ACTIVITY; BRAZIL; CHILD; CONFERENCE PAPER; DNA SEQUENCE; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; STRUCTURAL GENE; SURVIVAL RATE; TREATMENT FAILURE; VIRUS MUTATION;

EID: 14644443511     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-46652005000100001     Document Type: Conference Paper

References (16)

1. BACHELER, L.T.; ANTON, E.D.; KUDISH, P. et al. - Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob. Agents Chemother., 44: 2475-2484, 2000.
2. DICKOVER, R.E.; DILLON, M.; GILLETTE, S.G. et al. - Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J. infect. Dis., 170: 1279-1284, 1994.
3. ESHLEMAN, S.H.; KROGSTAD, P.; JACKSON, J.B. et al. - Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). J. infect. Dis., 183: 1732-1738, 2001.
4. GALLEGO, O.; RUIZ, L.; VALLEJO, A. et al. - Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain. J. clin. Microbiol., 40: 3865-3866, 2002.
5. GOMEZ-CANO, M.; RUBIO, A.; PUIG, T. et al. - Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS, 12: 1015-1020, 1998.
6. GORTMAKER, S.L.; HUGHES, M.; CERVIA, S. et al. - Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New Engl. J. Med., 345: 1522-1528, 2001.
7. GUIDELINES™ Rules 5.0 Available at: http://www.trugene.com/ Physicians/ GuidelineRules_5.0.pdf.
8. HIRSCH, M.S.; BRUN-VEZINET, F.; D'AQUILA, R.T. et al. - Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. J. Amer. med. Ass., 283: 2417-2426, 2000.
9. HOLGUIN, A.; DIETRICH, U.; IMMELMANN, A. & SORIANO, V. - Genotypic and phenotypic resistance to stavudine after long-term monotherapy. BMS-020 Spanish Study Group. Antivir. Ther., 3: 183-186, 1998.
10. MATIDA, L.H. - Estudo de sobrevida da AIDS em menores de 13 anos - Brasil. Bol. epidem. Ministério da Saúde, XV (2). Semanas Epidemiológicas 48A./2001-13A./ 2002.
11. SHEARER, W.T.; QUINN, T.C.; LA RUSSA, P. et al. - Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. New Engl. J. Med., 336: 1337-1342, 1997.
12. SHUURMAN, R.; DEMETER, L.; REICHELDERFER, P. et al. - Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type I reverse transcriptase. J. clin Microbiol., 37: 2291-2296, 1999.
13. SORIANO, V. - Sequencing antiretroviral drugs. AIDS, 15: 547-551, 2001.
14. STASZEWSKI, S.J.; MORALES-RAMIREZ, K.T. & TASHIMA , A. - Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. New Engl. J. Med., 341: 1865-1873, 1999.
15. SVEDHEM, V.; LINDKVIST, A.; LIDMAN, K. & SONNERBORG, A. - Persistence of earlier HIV-1 drug resistance mutations at new treatment failure. J. med. Virol., 68: 473-478, 2002.
16. WORKING GROUP ON ANTIRETROVIRAL THERAPY AND MEDICAL MANAGEMENT OF HIV INFECTED CHILDREN. 2004 - Guidelines for use of antiretroviral agents in pediatric HIV infection. Available at: http://www.hivatis.org.